Ethical and legal challenges in the secondary use of digital health records for public health research: A systematic review of Nordic governance models - 19/11/26

, R.I. Turhan c, 1
, I. Jafarli d, 1 
Highlights |
• | Review of 47 studies on secondary health-data governance in five Nordic states. |
• | Separates GDPR lawful basis, Article 9 conditions, Article 89 and research consent. |
• | National GDPR interpretation, not the GDPR itself, hampers Nordic data sharing. |
• | Privacy-enhancing technologies reduce, but do not remove, re-identification risk. |
• | The European Health Data Space may narrow access differences but not ethics rules. |
Abstract |
Background |
Secondary use of electronic health records (EHRs) and registries supports public health research and planning, yet reconciling data utility with data protection under the General Data Protection Regulation (GDPR) remains difficult. The Nordic countries, with population-wide registries and historically high public trust, provide an instructive setting for studying health-data governance.
Methodology |
Following PRISMA 2020, PubMed, Scopus, Web of Science and IEEE Xplore were searched for peer-reviewed studies published between April 2016 and May 2026 that examined ethical, legal or technical aspects of the secondary use of health records or registry data in Finland, Sweden, Norway, Denmark or Iceland. Of 516 records (371 after de-duplication), 54 full texts were assessed and 47 studies were included, appraised with the Mixed Methods Appraisal Tool or a text-and-opinion framework with doctrinal criteria, and synthesised thematically.
Results and discussion |
Sweden (24 studies), Denmark (18), Norway (18) and Finland (12) were well represented, Iceland only in multi-country studies (5). Four themes emerged: legal basis, consent and access governance (16 studies); identifiability and privacy-enhancing technologies (13); cross-border and multi-site sharing (12); and public trust and the social licence (6). Statutory, consent-free registry research remains the norm, but Finnish data show a marked fall in registry research permits after centralised permitting was introduced; national interpretation of the GDPR, rather than the Regulation itself, was repeatedly reported to impede Nordic collaboration; technical studies showed that de-identification, synthetic data and distributed computation reduce, but do not remove, disclosure risk; and public acceptance depended on information, oversight and the identity of the data user.
Conclusion and perspectives |
The evidence is heterogeneous and largely descriptive. It supports transparent permit practices, harmonised procedures and layered technical safeguards, and suggests that the European Health Data Space will narrow differences in access models while leaving ethics review and consent rules largely national.
Le texte complet de cet article est disponible en PDF.Keywords : Consent, Ethics, GDPR, Governance, Privacy, Pseudonymisation, Registries
Plan
Vol 34
Article 101361- 2026 Retour au numéroBienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?
